Actinomyces oris 371 is a facultative anaerobe, mesophilic, Gram-positive prokaryote that was isolated from Human, Cervico-facial actinomycosis.
Gram-positive rod-shaped facultative anaerobe mesophilic| @ref 20215 |
|
|
| Domain Bacteria |
| Phylum Actinomycetota |
| Class Actinomycetes |
| Order Actinomycetales |
| Family Actinomycetaceae |
| Genus Actinomyces |
| Species Actinomyces oris |
| Full scientific name Actinomyces oris Henssge et al. 2009 |
| @ref | Gram stain | Cell shape | Motility | |
|---|---|---|---|---|
| 38755 | positive | rod-shaped |
| @ref | Name | Growth | Composition | Medium link | |
|---|---|---|---|---|---|
| 38755 | MEDIUM 6 - Columbia agar with 10 % horse blood | Distilled water make up to (1000.000 ml);Columbia agar (39.000 g);Horseblood (100.000 ml) | |||
| 38755 | CIP Medium 6 | Medium recipe at CIP |
| 38755 | Oxygen tolerancefacultative anaerobe |
| @ref | Chebi-ID | Metabolite | Utilization activity | Kind of utilization tested | |
|---|---|---|---|---|---|
| 68371 | 27613 ChEBI | amygdalin | - | builds acid from | from API 50CH acid |
| 68371 | 18305 ChEBI | arbutin | - | builds acid from | from API 50CH acid |
| 68371 | 17057 ChEBI | cellobiose | - | builds acid from | from API 50CH acid |
| 38755 | 16947 ChEBI | citrate | - | carbon source | |
| 68371 | 17108 ChEBI | D-arabinose | - | builds acid from | from API 50CH acid |
| 68371 | 18333 ChEBI | D-arabitol | - | builds acid from | from API 50CH acid |
| 68371 | 28847 ChEBI | D-fucose | - | builds acid from | from API 50CH acid |
| 68371 | 62318 ChEBI | D-lyxose | - | builds acid from | from API 50CH acid |
| 68371 | 16899 ChEBI | D-mannitol | - | builds acid from | from API 50CH acid |
| 68371 | 16988 ChEBI | D-ribose | - | builds acid from | from API 50CH acid |
| 68371 | 17924 ChEBI | D-sorbitol | - | builds acid from | from API 50CH acid |
| 68371 | 16443 ChEBI | D-tagatose | - | builds acid from | from API 50CH acid |
| 68371 | 65327 ChEBI | D-xylose | - | builds acid from | from API 50CH acid |
| 68371 | 17113 ChEBI | erythritol | - | builds acid from | from API 50CH acid |
| 38755 | 4853 ChEBI | esculin | - | hydrolysis | |
| 68371 | 4853 ChEBI | esculin | - | builds acid from | from API 50CH acid |
| 68371 | 16813 ChEBI | galactitol | - | builds acid from | from API 50CH acid |
| 68371 | 28066 ChEBI | gentiobiose | - | builds acid from | from API 50CH acid |
| 68371 | 24265 ChEBI | gluconate | - | builds acid from | from API 50CH acid |
| 68371 | 28087 ChEBI | glycogen | - | builds acid from | from API 50CH acid |
| 38755 | 606565 ChEBI | hippurate | - | hydrolysis | |
| 68371 | 30849 ChEBI | L-arabinose | - | builds acid from | from API 50CH acid |
| 68371 | 18403 ChEBI | L-arabitol | - | builds acid from | from API 50CH acid |
| 68371 | 62345 ChEBI | L-rhamnose | - | builds acid from | from API 50CH acid |
| 68371 | 17266 ChEBI | L-sorbose | - | builds acid from | from API 50CH acid |
| 68371 | 65328 ChEBI | L-xylose | - | builds acid from | from API 50CH acid |
| 68371 | 6731 ChEBI | melezitose | - | builds acid from | from API 50CH acid |
| 68371 | 320061 ChEBI | methyl alpha-D-glucopyranoside | - | builds acid from | from API 50CH acid |
| 68371 | 43943 ChEBI | methyl alpha-D-mannoside | - | builds acid from | from API 50CH acid |
| 68371 | 74863 ChEBI | methyl beta-D-xylopyranoside | - | builds acid from | from API 50CH acid |
| 38755 | 17632 ChEBI | nitrate | - | reduction | |
| 38755 | 17632 ChEBI | nitrate | + | respiration | |
| 38755 | 16301 ChEBI | nitrite | - | reduction | |
| 68371 | Potassium 2-ketogluconate | - | builds acid from | from API 50CH acid | |
| 68371 | 15963 ChEBI | ribitol | - | builds acid from | from API 50CH acid |
| 68371 | 17814 ChEBI | salicin | - | builds acid from | from API 50CH acid |
| 68371 | 28017 ChEBI | starch | - | builds acid from | from API 50CH acid |
| 68371 | 27082 ChEBI | trehalose | - | builds acid from | from API 50CH acid |
| 68371 | 32528 ChEBI | turanose | - | builds acid from | from API 50CH acid |
| 68371 | 17151 ChEBI | xylitol | - | builds acid from | from API 50CH acid |
| @ref | Metabolite | Is sensitive | Is resistant | |
|---|---|---|---|---|
| 38755 | 0129 (2,4-Diamino-6,7-di-iso-propylpteridine phosphate) |
| @ref | Value | Activity | Ec | |
|---|---|---|---|---|
| 68382 | acid phosphatase | + | 3.1.3.2 | from API zym |
| 38755 | alcohol dehydrogenase | - | 1.1.1.1 | |
| 68382 | alkaline phosphatase | + | 3.1.3.1 | from API zym |
| 68382 | alpha-chymotrypsin | - | 3.4.21.1 | from API zym |
| 68382 | alpha-fucosidase | - | 3.2.1.51 | from API zym |
| 68382 | alpha-galactosidase | + | 3.2.1.22 | from API zym |
| 68382 | alpha-glucosidase | + | 3.2.1.20 | from API zym |
| 68382 | alpha-mannosidase | - | 3.2.1.24 | from API zym |
| 38755 | amylase | + | ||
| 68382 | beta-galactosidase | + | 3.2.1.23 | from API zym |
| 38755 | beta-galactosidase | + | 3.2.1.23 | |
| 68382 | beta-glucosidase | + | 3.2.1.21 | from API zym |
| 68382 | beta-glucuronidase | - | 3.2.1.31 | from API zym |
| 38755 | caseinase | - | 3.4.21.50 | |
| 38755 | catalase | + | 1.11.1.6 | |
| 68382 | cystine arylamidase | - | 3.4.11.3 | from API zym |
| 38755 | DNase | - | ||
| 68382 | esterase (C 4) | + | from API zym | |
| 68382 | esterase lipase (C 8) | + | from API zym | |
| 38755 | gamma-glutamyltransferase | - | 2.3.2.2 | |
| 38755 | gelatinase | - | ||
| 38755 | lecithinase | - | ||
| 68382 | leucine arylamidase | + | 3.4.11.1 | from API zym |
| 38755 | lipase | - | ||
| 68382 | lipase (C 14) | - | from API zym | |
| 38755 | lysine decarboxylase | - | 4.1.1.18 | |
| 68382 | N-acetyl-beta-glucosaminidase | - | 3.2.1.52 | from API zym |
| 68382 | naphthol-AS-BI-phosphohydrolase | + | from API zym | |
| 38755 | ornithine decarboxylase | - | 4.1.1.17 | |
| 38755 | oxidase | - | ||
| 38755 | phenylalanine ammonia-lyase | - | 4.3.1.24 | |
| 38755 | protease | - | ||
| 68382 | trypsin | - | 3.4.21.4 | from API zym |
| 38755 | tryptophan deaminase | - | ||
| 38755 | tween esterase | - | ||
| 38755 | urease | - | 3.5.1.5 | |
| 68382 | valine arylamidase | + | from API zym |
| @ref | ControlQ | GLY | ERY | DARA | LARA | RIB | DXYL | LXYL | ADO | MDX | GAL | GLU | FRU | MNE | SBE | RHA | DUL | INO | MAN | SOR | MDM | MDG | NAG | AMY | ARB | ESC | SAL | CEL | MAL | LAC | MEL | SAC | TRE | INU | MLZ | RAF | AMD | GLYG | XLT | GEN | TUR | LYX | TAG | DFUC | LFUC | DARL | LARL | GNT | 2KG | 5KG | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 38755 | not determinedn.d. | +/- | - | - | - | - | - | - | - | - | +/- | +/- | +/- | +/- | - | - | - | +/- | - | - | - | - | +/- | - | - | - | - | - | +/- | +/- | +/- | +/- | - | +/- | - | +/- | - | - | - | - | - | - | - | - | +/- | - | - | - | - | +/- |
| 38755 | Sample typeHuman, Cervico-facial actinomycosis |
| @ref | Biosafety level | Biosafety level comment | |
|---|---|---|---|
| 38755 | 2 | Risk group (French classification) |
| Topic | Title | Authors | Journal | DOI | Year | |
|---|---|---|---|---|---|---|
| Phylogeny | First Cultivation of Health-Associated Tannerella sp. HOT-286 (BU063). | Vartoukian SR, Moazzez RV, Paster BJ, Dewhirst FE, Wade WG. | J Dent Res | 10.1177/0022034516651078 | 2016 | |
| Metabolism | Dual function of a tip fimbrillin of Actinomyces in fimbrial assembly and receptor binding. | Wu C, Mishra A, Yang J, Cisar JO, Das A, Ton-That H. | J Bacteriol | 10.1128/jb.00173-11 | 2011 | |
| Microbial Biofilm Decontamination on Dental Implant Surfaces: A Mini Review. | Dhaliwal JS, Abd Rahman NA, Ming LC, Dhaliwal SKS, Knights J, Albuquerque Junior RF. | Front Cell Infect Microbiol | 10.3389/fcimb.2021.736186 | 2021 | ||
| Pathogenicity | Incorporation of antimicrobial agents can be used to enhance the antibacterial effect of endodontic sealers. | Gjorgievska E, Apostolska S, Dimkov A, Nicholson JW, Kaftandzieva A | Dent Mater | 10.1016/j.dental.2012.10.002 | 2012 | |
| Pathogenicity | Lipoproteins of Actinomyces viscosus induce inflammatory responses through TLR2 in human gingival epithelial cells and macrophages. | Shimada E, Kataoka H, Miyazawa Y, Yamamoto M, Igarashi T | Microbes Infect | 10.1016/j.micinf.2012.04.015 | 2012 | |
| Pathogenicity | [An in vitro study on effect of Nidus vespae extract on the acid production of three strains of oral bacteria]. | Zuo YL, Li JY, Xie Q, Zhou XD | Sichuan Da Xue Xue Bao Yi Xue Ban | 2005 | ||
| [The effect of galla chinensis on the growth of cariogenic bacteria in vitro]. | Xie Q, Li JY, Zuo YL, Zhou XD | Hua Xi Kou Qiang Yi Xue Za Zhi | 2005 | |||
| [The in vitro study on Polistes mandarinus' effects on cariogenic bacteria]. | Huang ZW, Xiao Y, Liu TJ, Zhou XD, Li JY, Zhan L | Shanghai Kou Qiang Yi Xue | 1094 | 2002 | ||
| [Comparison of the antibacterial activity on oral pathogens among six types of nano-silver base inorganic antibacterial agents]. | She WJ, Zhang FQ | Shanghai Kou Qiang Yi Xue | 1422 | 2003 | ||
| Biotechnology | [The in vitro study of the effects of 11 kinds of traditional Chinese medicine on the growth and acid production of Actinomyces viscosus]. | Xiao Y, Liu T, Huang Z, Zhou X, Li G | Hua Xi Yi Ke Da Xue Xue Bao | 2002 | ||
| Pathogenicity | [Effect of para-aminobenzoic acid on the growth of Actinomyces viscosus]. | Guo B, Zhou X, Xiao X, Li L, Zhu Z | Hua Xi Yi Ke Da Xue Xue Bao | 2002 | ||
| Pathogenicity | [The effects of tea polyphenols on the adherence of cariogenic bacterium to the collagen in vitro]. | Xiao Y, Liu T, Zhan L, Zhou X | Hua Xi Kou Qiang Yi Xue Za Zhi | 2000 | ||
| Pathogenicity | [The effects of tea polyphenols on the adherence of cariogenic bacterium to the salivary acquired pellicle in vitro]. | Xiao Y, Liu T, Zhan L, Zhou X | Hua Xi Kou Qiang Yi Xue Za Zhi | 2000 | ||
| Pathogenicity | [Experimental study of bacteriostatic activity of Chinese herbal medicines on primary cariogenic bacteria in vitro]. | Wang S, Fan M, Bian Z | Zhonghua Kou Qiang Yi Xue Za Zhi | 2001 | ||
| Pathogenicity | Comparison of corrosion behaviour in presence of oral bacteria. | Laurent F, Grosgogeat B, Reclaru L, Dalard F, Lissac M | Biomaterials | 10.1016/s0142-9612(00)00416-6 | 2001 | |
| Metabolism | Strains of Actinomyces naeslundii and Actinomyces viscosus exhibit structurally variant fimbrial subunit proteins and bind to different peptide motifs in salivary proteins. | Li T, Johansson I, Hay DI, Stromberg N | Infect Immun | 10.1128/IAI.67.5.2053-2059.1999 | 1999 | |
| Inhibition of a Porphyromonas gingivalis colonizing factor between Actinomyces viscosus ATCC 19246 by monoclonal antibodies against recombinant 40-kDa outer-membrane protein. | Saito S, Hiratsuka K, Hayakawa M, Takiguchi H, Abiko Y | Gen Pharmacol | 10.1016/s0306-3623(96)00366-7 | 1997 | ||
| Pathogenicity | Antibacterial action of dental cements: an in vitro study. | Morrier JJ, Rocca JP, Barsotti O | Bull Group Int Rech Sci Stomatol Odontol | 1995 | ||
| Pathogenicity | Induction of inflammatory cytokines by a soluble moiety prepared from an enzyme lysate of Actinomyces viscosus cell walls. | Takada H, Kimura S, Hamada S | J Med Microbiol | 10.1099/00222615-38-6-395 | 1993 | |
| Metabolism | Characterization of the binding of Actinomyces naeslundii (ATCC 12104) and Actinomyces viscosus (ATCC 19246) to glycosphingolipids, using a solid-phase overlay approach. | Stromberg N, Karlsson KA | J Biol Chem | S0021-9258(19)38584-9 | 1990 | |
| Enzymology | Purification and characterization of levanase from Actinomyces viscosus ATCC 19246. | Igarashi T, Takahashi M, Yamamoto A, Etoh Y, Takamori K | Infect Immun | 10.1128/iai.55.12.3001-3005.1987 | 1987 | |
| Surface localization of sialic acid on Actinomyces viscosus. | Jones AH, Lee CC, Moncla BJ, Robinovitch MR, Birdsell DC | J Gen Microbiol | 10.1099/00221287-132-12-3381 | 1986 | ||
| Metabolism | A possible mechanism for the cellular coaggregation between Actinomyces viscosus ATCC 19246 and Streptococcus sanguis ATCC 10557. | Sato S, Koga T, Inoue M | J Gen Microbiol | 10.1099/00221287-130-6-1351 | 1984 | |
| Enzymology | Novel antigens of oral Actinomyces species prepared from a cell wall enzyme lysate. | Hamada S, Okahashi N, Kimura S, Imanishi H, Koga T, Kawata S, Michalek SM, McGhee JR | Jpn J Med Sci Biol | 10.7883/yoken1952.35.171 | 1982 | |
| Pathogenicity | Quantitative fluorescent immunoassay of antibodies to, and surface antigens of, Actinomyces viscosus. | Gillis TP, Thompson JJ | J Clin Microbiol | 10.1128/jcm.7.2.202-208.1978 | 1978 | |
| Pathogenicity | Blastogenic response of human lymphocytes to oral bacterial antigens: characterization of bacterial sonicates. | Reed MJ, Patters MR, Mashimo PA, Genco RJ, Levine RJ | Infect Immun | 10.1128/iai.14.5.1202-1212.1976 | 1976 |
| #20215 | Parte, A.C., Sardà Carbasse, J., Meier-Kolthoff, J.P., Reimer, L.C. and Göker, M.: List of Prokaryotic names with Standing in Nomenclature (LPSN) moves to the DSMZ. IJSEM ( DOI 10.1099/ijsem.0.004332 ) |
| #38755 | Collection of Institut Pasteur ; Curators of the CIP; CIP 100655 |
| #68371 | Automatically annotated from API 50CH acid . |
| #68382 | Automatically annotated from API zym . |
| #126262 | A. Lissin, I. Schober, J. F. Witte, H. Lüken, A. Podstawka, J. Koblitz, B. Bunk, P. Dawyndt, P. Vandamme, P. de Vos, J. Overmann, L. C. Reimer: StrainInfo—the central database for linked microbial strain identifiers. ( DOI 10.1093/database/baaf059 ) |
You found an error in BacDive? Please tell us about it!
Note that changes will be reviewed and judged. If your changes are legitimate, changes will occur within the next BacDive update. Only proposed changes supported by the according reference will be reviewed. The BacDive team reserves the right to reject proposed changes.
Successfully sent
If you want to cite this particular strain cite the following doi:
https://doi.org/10.13145/bacdive137810.20251217.10
When using BacDive for research please cite the following paper
BacDive in 2025: the core database for prokaryotic strain data